Development of a mechanistically-based genetically engineered PC12 cell system to detect p53-mediated cytotoxicity

Toxicology in Vitro

Volumn 21, Issue 4, 2007, Pages 698-705

  van Vliet, Erwin ^a   Eskes, Chantra ^a   Stingele, Silvia ^a   Gartlon, Joanne ^a   Price, Anna ^a   Farina, Massimo ^a   Ponti, Jessica ^a   Hartung, Thomas ^a   Sabbioni, Enrico ^a   Coecke, Sandra ^a  

^a JOINT RESEARCH CENTRE   (Italy)

Author keywords

Apoptosis; Arsenic; Camptothecin; In vitro; Mercury; Metals; p53

Indexed keywords

ARSENITE SODIUM; CAMPTOTHECIN; CARCINOGEN; METHYLMERCURY; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CYTOTOXICITY; GENE EXPRESSION; GENETIC ENGINEERING; IN VITRO STUDY; NECROSIS; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARSENITES; BLOTTING, WESTERN; CAMPTOTHECIN; CELL DIFFERENTIATION; CELL SURVIVAL; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; FLOW CYTOMETRY; GENES, P53; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; INDICATORS AND REAGENTS; METHYLMERCURY COMPOUNDS; NEUROTOXINS; PC12 CELLS; RATS; TRACE ELEMENTS; TRANSFECTION;

EID: 34047244235     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.12.004     Document Type: Article

References (43)

1. Anselmi C., Ettorre A., Andreassi M., Centini M., Neri P., and Di Stefano A. In vitro induction of apoptosis vs. necrosis by widely used preservatives: 2-phenoxyethanol, a mixture of isothiazolinones, imidazolidinyl urea and 1,2-pentanediol. Biochemical Pharmacology 63 (2002) 437-453
2. Biswas S.C., Ryu E., Park C., Malagelada C., and Greene L.A. Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease. Neurochemistry Research 30 (2005) 839-845
3. Bode A.M., and Dong Z. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Critical Reviews in Oncology/Hematology 42 (2002) 5-24
4. Chen S.C., Chen C.H., Chern C.L., Hsu L.S., Huang Y.C., Chung K.T., and Chye S.M. p-Phenylenediamine induces p53-mediated apoptosis in Mardin-Darby canine kidney cells. Toxicology In Vitro 20 (2006) 801-807
5. Clarkson T.W. The three modern faces of mercury. Environmental Health Perspectives (2002) 11-23
6. Coecke S., Eskes C., Gartlon J., van Vliet E., Kinsner A., Bogni A., Raimondo L., Parissis N., and Langezaal I. Metabolism and neurotoxicity: the significance of genetically engineered cell lines and new three-dimensional cell cultures. ATLA 30 S2 (2002) 115-118
7. Coecke S., Balls M., Bowe G., Davis J., Gstraunthaler G., Hartung T., Hay R., Merten O.W., Price A., Schechtman L., Stacey G., Stokes W., and Patlewicz G. Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice. Alternatives to Laboratory Animals: ATLA 33 (2005) 261-287
8. Coecke S., Eskes C., Gartlon J., Kinsner A., Price A., van Vliet E., Prieto P., Boveri M., Bremer S., Adler S., Pellizzer C., Wendel A., and Hartung T. The value of alternative testing for neurotoxicity in the context of regulatory needs. Environmental Toxicology and Pharmacology 21 (2006) 153-167
9. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunology Methods 89 (1986) 271-277
10. Duerksen-Hughes P.J., Yang J., and Schwartz S.B. HPV 16 E6 blocks TNF-mediated apoptosis in mouse fibroblast LM cells. Virology 264 (1999) 55-65
11. Fang M.Z., Mar W., and Cho M.H. Cadmium affects genes involved in growth regulation during two-stage transformation of Balb/3T3 cells. Toxicology 177 (2002) 253-265
12. Florea A.M., and Busselberg D. Occurrence, use and potential toxic effects of metals and metal compounds. Biometals 4 (2006) 419-427
13. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 5547-5551
14. Greenblatt M.S., Bennett W.P., Hollstein M., and Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research 54 (1994) 4855-4878
15. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America 7 (1976) 2424-2428
16. Hagopian G.S., Mills G.B., Khokhar A.R., Bast Jr. R.C., and Siddik Z.H. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Clinical Cancer Research 5 (1999) 655-663
17. Hofer T., Gerner I., Gundert-Remy U., Liebsch M., Schulte A., Spielmann H., Vogel R., and Wettig K. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation. Archives of Toxicology 78 (2004) 549-564
18. IARC: .
19. Kaiser H.E., and Bodey B. The role of apoptosis in normal ontogenesis and solid human neoplasms. In Vivo 14 (2000) 789-803
20. Lesuisse C., and Martin L.J. Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway. Journal of Cerebral Blood Flow and Metabolism 22 (2002) 935-950
21. Magrini R., Bhonde M.R., Hanski M.L., Notter M., Scherubl H., Boland C.R., Zeitz M., and Hanski C. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status. International Journal of Cancer 101 (2002) 23-31
22. May P., and May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18 (1999) 7621-7636
23. Miller F.D., Pozniak C.D., and Walsh G.S. Neuronal life and death: an essential role for the p53 family. Cell Death and Differentiation 7 (2000) 880-888
24. Miura K., Koide N., Himeno S., Nakagawa I., and Imura N. The involvement of microtubular disruption in methylmercury-induced apoptosis in neuronal and nonneuronal cell lines. Toxicology and Applied Pharmacology 160 (1999) 279-288
25. Monnet-Tschudi F., Zurich M.G., and Honegger P. Comparison of the developmental effects of two mercury compounds on glial cells and neurons in aggregate cultures of rat telencephalon. Brain Research 741 (1996) 52-59
26. Nakajima Y., Nakamura T., Enomoto T., and Murata Y. Loss of one allele of the p53 gene in the lens epithelial tumor in transgenic mice suppresses apoptosis induced by a topoisomerase I inhibitor (CPT-11). Cancer Letters 179 (2002) 165-173
27. Nicotera P. The Gerhard Zbinden Memorial Lecture. Alteration of cell signalling in chemical toxicity. Archives of Toxicology Supplement 18 (1996) 3-11
28. Ohyagi Y., Asahara H., Chui D.H., Tsuruta Y., Sakae N., Miyoshi K., Yamada T., Kikuchi H., Taniwaki T., Murai H., Ikezoe K., Furuya H., Kawarabayashi T., Shoji M., Checler F., Iwaki T., Makifuchi T., Takeda K., Kira J., and Tabira T. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 19 (2005) 255-257
29. Potera C. Therapies seek control of apoptosis. Designing therapeutics for autoimmune disorders, cancer and hearth diseases. Genetic Engineering News 18 (1998) 9-41
30. Raza H., and John A. 4-Hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells. Toxicol Applied Pharmacology 2 (2006) 309-318
31. Schulte-Hermann R., Bursch W., Marian B., and Grasl-Kraupp B. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens. IARC Scientific Publications 146 (1999) 273-285
32. Stingele, S., Coecke, S., Nicotera, P., Balls, M., 1999. EC Patent filed 27th of august 1999 on "Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing. European Patent Office. Rijswijk, The Netherlands, Patent No. 99402139.2-2106/International No. PCT/EP00/08223.
33. Striteska D. The tumor supressor gene p53. Acta medica (Hradec Králové). Supplementum Universitas Carolina, Facultas Medica Hradec Králové 48 (2005) 21-25
34. Suzuki T., and Tsukamoto I. Manganese-induced apoptosis in hepatocytes after partial hepatectomy. European Journal of Pharmacology 525 (2005) 48-53
35. USEPA, 1990. Health and Environmental Effects. Document for Molybdenum and Selected Molybdenum Compounds. USEPA, Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH, ECAO-CIN-G070.
36. Valko M., Morris H., and Cronin M.T. Metals, toxicity and oxidative stress. Current Medicinal Chemistry 10 (2005) 1161-1208
37. Vanlandingham J.W., Tassabehji N.M., Somers R.C., and Levenson C.W. Expression profiling of p53-target genes in copper-mediated neuronal apoptosis. Neuromolecular Medicine 7 (2005) 311-324
38. Vogt B.L., and Rossman T.G. Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts - a possible mechanism for arsenite's comutagenicity. Mutation Research 478 (2001) 159-168
39. Waisberg M., Joseph P., Hale B., and Beyersmann D. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192 (2003) 95-117
40. Wang L.Z., Sun W.C., and Zhu X.Z. Ethyl pyruvate protects PC12 cells from dopamine-induced apoptosis. European Journal of Pharmacology 1-3 (2005) 57-68
41. Wosik K., Antel J., Kuhlmann T., Bruck W., Massie B., and Nalbantoglu J. Oligodendrocyte injury in multiple sclerosis: a role for p53. Journal of Neurochemistry 85 (2003) 635-644
42. Ye J., Wang S., Leonard S.S., Sun Y., Butterworth L., Antonini J., Ding M., Rojanasakul Y., Vallyathan V., Castranova V., and Shi X. Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. The Journal of Biological Chemistry 274 (1999) 34974-34980
43. Zhao W.Q., Williams Z., Shepherd K.R., Reuben J.S., Lee E.S., Darling-Reed S., Lamango N., Soliman K.F., and Charlton C.G. S-adenosyl-methionine-induced apoptosis in PC12 cells. Journal of Neuroscience Research 4 (2002) 519-529